Advertisement

Topics

Mylan Calls Allergan Restasis Patent Deal A 'Desperate Tactic'

13:03 EDT 13 Sep 2017 | SCRIP

Allergan's potential Restasis generic rival wasted no time attacking the company in court documents over the controversial deal Allergan signed...

      

Related Stories

 

Original Article: Mylan Calls Allergan Restasis Patent Deal A 'Desperate Tactic'

NEXT ARTICLE

More From BioPortfolio on "Mylan Calls Allergan Restasis Patent Deal A 'Desperate Tactic'"

Quick Search
Advertisement
 

Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...